1. Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver
   Adhyatmika Adhyatmika et al, 2020, Pharmaceutics CrossRef
2. HepatoScore‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk
   Jeffrey S. Morris et al, 2021, Hepatology CrossRef
3. PTSD and the klotho longevity gene: Evaluation of longitudinal effects on inflammation via DNA methylation
   Erika J. Wolf et al, 2020, Psychoneuroendocrinology CrossRef
4. Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease
   Krisztián Vörös et al, 2023, PLOS ONE CrossRef
5. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives
   Federico Monti et al, 2024, International Journal of Molecular Sciences CrossRef
6. Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?
   Panagiotis V. Katsaounis et al, 2023, Scandinavian Journal of Gastroenterology CrossRef
7. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016
   Zhenfei Chi et al, 2023, Annals of Hepatology CrossRef
8. Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence
   Milos Stulic et al, 2024, Diagnostics CrossRef
9. Apelin/APJ system: A critical regulator of vascular smooth muscle cell
   Xuling Luo et al, 2018, Journal of Cellular Physiology CrossRef
10. Non-alcoholic fatty liver disease and liver secretome
    Muhammad Sohaib Khan et al, 2022, Archives of Pharmacal Research CrossRef
11. Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of Osteoprotegerin
    Niklas Rye Jørgensen et al, 2022, The Journal of Clinical Endocrinology & Metabolism CrossRef
12. Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis
    Xiaowen Zhang et al, 2024, The Journal of Clinical Endocrinology & Metabolism CrossRef
13. Soluble Klotho and Brain Atrophy in Alcoholism
    Emilio González-Reimers et al, 2018, Alcohol and Alcoholism CrossRef
14. Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients
    Esra Yazici et al, 2019, Nordic Journal of Psychiatry CrossRef
15. The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases
    Habibie Habibie et al, 2021, Pharmacology & Therapeutics CrossRef
16. Soluble α-Klotho in Liver Cirrhosis and Alcoholism
    C Martín-González et al, 2019, Alcohol and Alcoholism CrossRef
17. Klotho Levels and Their Relationship with Inflammation and Survival among Alcoholic Patients
    Candelaria Martín-González et al, 2022, Biomolecules CrossRef